These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 16515984

  • 1. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer.
    Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Presti JC, Terris MK, SEARCH Database Study Group.
    J Urol; 2006 Apr; 175(4):1298-302; discussion 1302-3. PubMed ID: 16515984
    [Abstract] [Full Text] [Related]

  • 2. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ.
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [Abstract] [Full Text] [Related]

  • 3. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, Presti JC, Mangold LA, Humphreys E, Epstein JI, Partin AW, Freedland SJ.
    Cancer; 2006 Sep 15; 107(6):1265-72. PubMed ID: 16900523
    [Abstract] [Full Text] [Related]

  • 4. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
    Makarov DV, Humphreys EB, Mangold LA, Walsh PC, Partin AW, Epstein JI, Freedland SJ.
    J Urol; 2006 Aug 15; 176(2):554-8. PubMed ID: 16813888
    [Abstract] [Full Text] [Related]

  • 5. Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?
    Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ.
    J Urol; 2006 Dec 15; 176(6 Pt 1):2453-8; discussion 2458. PubMed ID: 17085127
    [Abstract] [Full Text] [Related]

  • 6. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [Abstract] [Full Text] [Related]

  • 7. Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?
    Graefen M, Walz J, Chun KH, Schlomm T, Haese A, Huland H.
    Eur Urol; 2005 Jun 15; 47(6):756-60. PubMed ID: 15925069
    [Abstract] [Full Text] [Related]

  • 8. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL.
    Eur Urol; 2008 Apr 15; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [Abstract] [Full Text] [Related]

  • 9. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
    Freedland SJ, Grubb KA, Yiu SK, Humphreys EB, Nielsen ME, Mangold LA, Isaacs WB, Partin AW.
    J Urol; 2005 Sep 15; 174(3):919-22. PubMed ID: 16093988
    [Abstract] [Full Text] [Related]

  • 10. Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database.
    Buschemeyer WC, Hamilton RJ, Aronson WJ, Presti JC, Terris MK, Kane CJ, Amling CL, Freedland SJ.
    J Urol; 2008 Jan 15; 179(1):124-9; discussion 129. PubMed ID: 17997433
    [Abstract] [Full Text] [Related]

  • 11. Changing nature of high risk patients undergoing radical prostatectomy.
    Kane CJ, Presti JC, Amling CL, Aronson WJ, Terris MK, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Jan 15; 177(1):113-7. PubMed ID: 17162017
    [Abstract] [Full Text] [Related]

  • 12. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Boorjian SA, Bianco FJ, Scardino PT, Eastham JA.
    BJU Int; 2005 Oct 15; 96(6):773-6. PubMed ID: 16153197
    [Abstract] [Full Text] [Related]

  • 13. Pathological features after radical prostatectomy in potential candidates for active monitoring.
    Griffin CR, Yu X, Loeb S, Desireddi VN, Han M, Graif T, Catalona WJ.
    J Urol; 2007 Sep 15; 178(3 Pt 1):860-3; discussion 863. PubMed ID: 17631347
    [Abstract] [Full Text] [Related]

  • 14. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.
    Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Partin AW.
    J Urol; 2006 Oct 15; 176(4 Pt 1):1404-8. PubMed ID: 16952644
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML.
    J Urol; 2007 Sep 15; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [Abstract] [Full Text] [Related]

  • 16. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
    Freedland SJ, Grubb KA, Yiu SK, Nielsen ME, Mangold LA, Isaacs WB, Epstein JI, Partin AW.
    J Urol; 2005 Nov 15; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
    [Abstract] [Full Text] [Related]

  • 17. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [Abstract] [Full Text] [Related]

  • 18. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H.
    BJU Int; 2008 Jan 15; 101(2):170-4. PubMed ID: 18173824
    [Abstract] [Full Text] [Related]

  • 19. Percent tumor involvement and risk of biochemical progression after radical prostatectomy.
    Rampersaud EN, Sun L, Moul JW, Madden J, Freedland SJ.
    J Urol; 2008 Aug 15; 180(2):571-6; discussion 576. PubMed ID: 18554662
    [Abstract] [Full Text] [Related]

  • 20. Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years.
    Freedland SJ, Isaacs WB, Mangold LA, Yiu SK, Grubb KA, Partin AW, Epstein JI, Walsh PC, Platz EA.
    Clin Cancer Res; 2005 Apr 15; 11(8):2883-8. PubMed ID: 15837737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.